As the official journal of the Asian Association for the Study of Diabetes (AASD), Journal of Diabetes Investigation is a clinical and experimental diabetes research journal encompassing basic science, clinical practice, and epidemiology in diabetes. Our scope also covers related areas including prevention and treatment, as well as molecular aspects and pathophysiology.

We publish translational research, providing a forum for clinicians and researchers to exchange ideas.

Journal Metrics

  • 6.5CiteScore
  • 3.1Journal Impact Factor
  • 34%Acceptance rate
  • 25 days Submission to first decision
view all metrics

Articles

“JDI Updates” are at-a-glance articles to stay up-to-date on hot topics in diabetes.


Please read the virtual issue on Insulin Secretion/β-cell

Open access

The cholesterol‐HDL‐glucose (CHG) index and traditional adiposity markers in predicting diabetic retinopathy and nephropathy

Graphical Abstract

The cholesterol-HDL-glucose (CHG) index and traditional adiposity markers in predicting diabetic retinopathy and nephropathy Issue ,

This study explores the association of visceral adiposity index (VAI) and lipid accumulation product (LAP), markers of visceral adiposity, with diabetic nephropathy and retinopathy. The findings revealed that VAI and LAP values were significantly elevated in diabetic nephropathy but showed no significant association with diabetic retinopathy. These results suggest a potential role of visceral adiposity in the pathogenesis of renal complications.

Open access

PIK3R1 mutations in individuals with insulin resistance or growth retardation: Case series and in silico functional analysis

Graphical Abstract

PIK3R1 mutations in individuals with insulin resistance or growth retardation: Case series and in silico functional analysis Issue ,

We present a report on SHORT syndrome caused by PIK3R1 mutations, including findings from in silico analysis. Our results demonstrate that these mutations impair the ability of p85α to interact with phosphopeptides.

Open access

Diabetes advocacy in the Asia–Pacific region

Graphical Abstract

Diabetes advocacy in the Asia–Pacific region Issue ,

Advocacy efforts to reduce the burdens of people with diabetes are growing. However, the situation varies significantly across countries and in our Asia–Pacific region. Through mutual understanding and collaboration, we aim to strengthen advocacy efforts across the Asia–Pacific region and contribute to global initiatives that enhance health outcomes for people with diabetes.

Open access

A case of SHORT syndrome with a novel genetic mutation diagnosed 19 years after the onset of diabetes

Graphical Abstract

A case of SHORT syndrome with a novel genetic mutation diagnosed 19 years after the onset of diabetes Issue ,

We report a case of SHORT syndrome caused by a novel PIK3R1 mutation. The diagnosis of SHORT syndrome was made based on typical clinical features suggestive of the syndrome.

Open access

Clinical use and monitoring of adverse effects of sodium‐glucose cotransporter‐2 inhibitors in persons with type 1 diabetes mellitus

Graphical Abstract

Clinical use and monitoring of adverse effects of sodium-glucose cotransporter-2 inhibitors in persons with type 1 diabetes mellitus Issue ,

Multiple regression analysis revealed that diuretic use was an independent risk factor for discontinuation of SGLT2i.

Open access

Young‐onset type 2 diabetes—Epidemiology, pathophysiology, and management

Graphical Abstract

Young-onset type 2 diabetes—Epidemiology, pathophysiology, and management Issue ,

The burden of young-onset type 2 diabetes is increasing globally, disproportionately affecting non-White ethnic groups and low- and middle-income countries. Young-onset type 2 is more heterogeneous regarding the genetic and environmental contributions to its underlying pathophysiology, which poses challenges for glycemic management. This review summarizes recent studies on the epidemiology of young-onset type 2 diabetes and its complications, discusses the genetic and environmental risk factors, and provides insights on diabetes prevention and management to address the unique medical and psychosocial issues associated with young-onset type 2 diabetes.

Open access

A 90 g/day low‐carbohydrate diet improved glycemic control without decreasing frailty in older patients with type 2 diabetes: A secondary analysis of a randomized controlled trial

Graphical Abstract

A 90 g/day low-carbohydrate diet improved glycemic control without decreasing frailty in older patients with type 2 diabetes: A secondary analysis of a randomized controlled trial Issue ,

A 90 g/day low-carbohydrate diet improved glycemic control with significantly lower waist circumference. After dietary interventions, the proportions of robust, pre-frailty, and frailty were not statistically significant between the traditional diabetic diet and low-carbohydrate diet groups.

Open access

Elevated amputation rates in COVID-19 survivors: Insights from a large-scale Japanese cohort study

Graphical Abstract

Elevated amputation rates in COVID-19 survivors: Insights from a large-scale Japanese cohort study Issue ,

COVID-19 is associated with a long-term increased risk of amputation, persisting for more than 2 years post infection. These findings highlight the need for vigilant vascular monitoring and early intervention to mitigate the long-term complications of COVID-19.

Open access

Uhrf1 downregulation promotes β‐cell dedifferentiation by decreasing Foxo1 expression in type 2 diabetes

Graphical Abstract

Uhrf1 downregulation promotes β-cell dedifferentiation by decreasing Foxo1 expression in type 2 diabetes Issue ,

This finding reveals the important role of Uhrf1 in the β-cell dedifferentiation of T2D, providing a potential target for its treatment.

More articles
More articles

Latest news